Kondo M
Nihon Rinsho. 1995 Jun;53(6):1357-63.
Contrary to the belief that porphyrias are of relatively rare occurrence, there has recently been a rapidly increasing number of reported cases of the disease apparently as a result of growing interest of clinicians, the advance of biochemical and molecular biological research works and improvement and refinement of diagnostic techniques. Unfortunately, however, it is an unquestionable fact that porphyrias are not infrequently still misdiagnosed. Detection and identification of the porphyrias constitutes an important step in the treatment of the diseases and, accordingly, determination of porphyrins and their precursors is of paramount therapeutic importance. While porphyrins are normally detected in small amounts in healthy individuals, these compounds are excreted in large quantities in the urine or feces or both in hereditary and chemical porphyrias, owing to inborn errors in heme biosynthesis and in hemolytic anemia, as a result of excessive production, resulting from increased heme biosynthesis. It follows that determination of porphyrins and their precursors in clinical materials is of pivotal importance in establishing the diagnosis of porphyrias. This paper reviews the methods of determination of porphyrins and their precursors in clinical materials and techniques employed for this purpose.
与卟啉症相对罕见的看法相反,最近报告的该疾病病例数量迅速增加,这显然是由于临床医生的兴趣日益浓厚、生化和分子生物学研究工作的进展以及诊断技术的改进和完善。然而,不幸的是,卟啉症仍时常被误诊,这是一个不容置疑的事实。卟啉症的检测和鉴定是该疾病治疗的重要一步,因此,卟啉及其前体的测定具有至关重要的治疗意义。虽然健康个体中通常只能检测到少量卟啉,但在遗传性和化学性卟啉症中,由于血红素生物合成的先天性缺陷以及溶血性贫血中血红素生物合成增加导致过量产生,这些化合物会大量排泄到尿液或粪便中,或两者皆有。因此,在临床材料中测定卟啉及其前体对于确立卟啉症的诊断至关重要。本文综述了临床材料中卟啉及其前体的测定方法以及为此目的所采用的技术。